Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia: Part II of a Prospective, Randomized Controlled, Multi-Institutional Trial

NCT04373941 is registered in ClinicalTrials.gov with Holterman, Ai-Xuan, M.D. as lead sponsor.

NCT NCT04373941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04373941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia: Part II of a Prospective, Randomized Controlled, Multi-Institutional Trial
Lead sponsor
Holterman, Ai-Xuan, M.D.
Phase
Phase 2
Overall status
Unknown status
Start date
September 1, 2023
Completion date
October 31, 2025
Enrollment
400 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

biliary atresia